Condition: Moderate to Severe Asthma · Sponsor: University of California, San Diego
In this study, a new method will be used to evaluate response to 2 approved biologic therapies, and assess how well each patient responds to each asthma treatment. This study will measure the response to these treatments using genomic and biologic measurements obtained from participants biosamples. By evaluating response to 2 different biologic therapies, this study has the potential to provide an in-depth understanding of the mechanisms underlying severe asthma that will inform and change treatment decisions, and may ultimately lead to a change in the way that asthma patients are evaluated for potential personalized therapies and maximize the probability that the subject will respond to treatment.
This description comes directly from the study's public registry record.
Clinical Trial Operations and Data Management Specialist UA-DCC · 520-626-9552 · bio5-epiphanydcc@arizona.edu
Always discuss trial participation with your own doctor first.
| Mayo Clinic | Scottsdale, Arizona, United States | Recruiting |
| University of California, San Diego | La Jolla, California, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06385236